Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Nov 4, 2014 · 10-Q · 35 days after period end · 0001193125-14-396273
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$291.00K | $900.00K | -$975.00K | -$143.00K |
| EPS Diluted | -$0.01 | $0.02 | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 4, 2014 · 35 d after period end
